Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-FATP2 Antibody (4L226) is a Mouse antibody targeting FATP2. Anti-FATP2 Antibody (4L226) can be used in WB,IHC.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $298 | 7-10 days | |
100 μL | $426 | 7-10 days |
Description | Anti-FATP2 Antibody (4L226) is a Mouse antibody targeting FATP2. Anti-FATP2 Antibody (4L226) can be used in WB,IHC. |
Synonyms | VLCS, VLACS, Very long-chain-fatty-acid-CoA ligase, Very long-chain acyl-CoA synthetase, very long-chain 1, Very long chain fatty acid coenzyme A ligase 1, Very long chain fatty acid CoA ligase, Very long chain acyl CoA synthetase, THCA-CoA ligase, THCA CoA ligase, Solute carrier family 27 member 2, Solute carrier family 27 (fatty acid transporter), member 2, Slc27a2, S27A2_HUMAN, Long-chain-fatty-acid--CoA ligase, Long chain fatty acid CoA ligase, HsT17226, hFACVL1, Fatty-acid-coenzyme A ligase, Fatty acid transport protein 2, Fatty acid coenzyme A ligase, very long chain 1, FATP-2, FATP2, FATP 2, FACVL1, ACSVL1 |
Clone | 4L226 |
Reactivity | Human |
Verified Activity | 1. Western blot analysis of FATP2 on human FATP2 recombinant protein using anti- FATP2 antibody at 1/1,000 dilution. 2. Western blot analysis of FATP2 on HEK293 (1) and FATP2-hIgGFc transfected HEK293 (2) cell lysate using anti-FATP2 antibody at 1/1,000 dilution. 3. Immunohistochemical analysis of paraffin-embedded human liver cancer tissue using anti-FATP2 antibody. Counter stained with hematoxylin. 4. Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissue using anti- FATP2 antibody. Counter stained with hematoxylin. |
Application | |
Recommended Dose | WB: 1:500-2000; IHC: 1:100-200 |
Antibody Type | Monoclonal |
Host Species | Mouse |
Construction | Hybridoma Monoclonal Antibody |
Purification | ProA affinity purified |
Appearance | Liquid |
Formulation | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
Research Background | Acyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precurors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes. |
Conjucates | Unconjugated |
Immunogen | Recombinant Protein |
Uniprot ID |
Molecular Weight | Theoretical: 70 kDa. |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.